NT-proBNP is a more sensitive and specific biomarker for the prediction of future atrial fibrillation than for forthcoming onset of heart failure: results from the observational DIAST-CHF study
Elevated levels of BNP and fibroblast growth factor 23 in patients with atrial fibrillation : an analysis of 40 cardiovascular biomarkers in 667 unselected hospitalized patients.
Preferential association of biomarkers with post-ablation recurrence in non-paroxysmal atrial fibrillation indicates the role of inflammation in persistence of the arrhythmia